Higher PEEP ventilation strategy in patients with acute respiratory distress syndrome: a systematic review and meta-analysis
Not Applicable
- Conditions
- Acute respiratory distress syndrome (ARDS)
- Registration Number
- JPRN-UMIN000041074
- Lead Sponsor
- Graduate school of medicine and public health, Kyoto University Department of Healthcare Epidemiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria (any of which are met) Controlled by noninvasive ventilation (NIV)
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 28-day mortality: If 28-day mortality is not reported, hospital mortality or mortality at the nearest-follow-up will be employed. If the Kaplan-Meier curve is reported, it is read from that figure.
- Secondary Outcome Measures
Name Time Method ong term mortality: longest follow-up regardless of the duration of follow-up will be employed ADLs: ADLs measured by one of the following a) Barthel Index, Katz Index, DASC-21, Lawton b) component of measurements of QOLs c) Author's definition QoL: A QoL measured by one of the following a) Short Form 36 (SF-36) (18) b) Health Assessment Questionnaire (HAQ) c) Sick ness profile impact (SIP)(19) d) other P/F: PaO2, FiO2 ratio for Day 1 (not including the baseline) VFD at 28: Ventilation free day up to 28 days. Barotrauma/ VILI: New pneumothorax, mediastinal emphysema, subcutaneous emphysema, new thoracic drainage, or author-defined Barotrauma/ VILI.